Tag: protein phosphorylations

Press Releases

Olink AB and Bethyl sign distribution agreement for the US market

Nov 21, 2011 09:00 EST Olink Bioscience, a Sweden based biotechnology company focused on innovative protein detection technologies, has entered into a distribution agreement with Bethyl Laboratories, Inc. Together with Bethyl Olink Bioscience will continue to expand the distribution of the Duolink® product line in the US market.

Aug 29, 2011 08:20 EDT nxt2b (Nexttobe AB) an investment company owned by Bengt Ågerup, has today signed an agreement with a group of shareholders in Olink AB to purchase 49 % of the outstanding shares in the company. The intention is to accelerate the growth and value creation of the company by injecting knowledge, experience and financial strength to complement Olink’s unique product and technology position.

Olink Bioscience and Sapphire Bioscience sign a distributorship agreement for the Australian & New Zealand market.

Mar 24, 2011 04:00 EDT Olink Bioscience has signed a distributorship agreement with Sapphire Bioscience for the distribution of the Duolink® product line in Australia and New Zealand.

Show all 10 press releases »

News

New products; Duolink® II Detection Reagents Far Red and Green

Oct 11, 2010 09:27 EDT Olink Bioscience launches two new Detection Reagents; Duolink® II Detection Reagents Far Red and Green.

Videos

Detect Protein Interactions in Fixed Cells and Tissues by Duolink®

Sep 25, 2009 05:20 EDT The Duolink® kit from Olink Bioscience enables researchers to use existing antibodies to detect single molecular events, such as protein interactions in unmodified cells and tissue sections. Duolink is based on in situ PLA™ which has the resolution and sensitivity to visualize post-translational modifications and protein interactions, which are fundamental processes in cell signaling pathways.
Length  43:12

Contact persons

Mats Gullberg - Cheif Technology  Officer

Previously Dr Gullberg worked for 10 years at Uppsala University where he also earned his Ph.D. The focus of his work since 1999 has been proximity ligation, rolling circle amplification and selector technology, all core technologies of Olink Bioscience.

Björn Ekström

Mr. Ekström has many years of experience in the biotech tools industry, including 18 years with Pharmacia Biotech (now GE Healthcare) in leading R&D positions, of which 5 years as Director of Exploratory Research. In this position, he was responsible for R&D projects that subsequently led to two spin-out companies, Gyros AB and Åmic AB. In 1997, he participated in the foundation of...